Reimportation Law Unlikely This Year Despite Democratic Pressure
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate Majority Leader Frist says he does not expect to fit Rx import language into the schedule during the session’s remaining days. The Senate Health Committee has no plans to markup a bill.
You may also be interested in...
Reimportation Is "Phony" Issue, Waxman Says, But Driven By Real Pricing Problems
Reimportation is not the solution to high U.S. drug prices, Rep. Henry Waxman (D-Calif.) said
Reimportation Is "Phony" Issue, Waxman Says, But Driven By Real Pricing Problems
Reimportation is not the solution to high U.S. drug prices, Rep. Henry Waxman (D-Calif.) said
Reimportation Advocates Have Support Of "Rogue" Pfizer Exec
Parallel trade of pharmaceuticals in Europe demonstrates that U.S. could safely implement an importation program, Pfizer VP-Marketing Peter Rost says at Capitol Hill press conference. Rost is a former Pharmacia exec who describes his advocacy as a "private citizen" sharing "personal experience."